Randomised double-blind placebo-controlled trial of aloe vera for irritable bowel syndrome

International Journal of Clinical Practice

Volumn 60, Issue 9, 2006, Pages 1080-1086

  Davis, K ^a   Philpott, S ^b   Kumar, D ^a   Mendall, Mike ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Aloe vera; Irritable bowel syndrome; Outcomes; Randomised controlled trial; Symptoms

Indexed keywords

ALOE VERA EXTRACT; PLACEBO; SPASMOLYTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; ALOE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; TREATMENT OUTCOME;

EID: 33747195004     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.00980.x     Document Type: Article

References (17)

1. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992; 304: 87-90.
2. Heaton KW, O'Donnel LJ, Braddon FE et al. Symptoms of irritable bowel syndrome in a British urban community: Consulters and nonconsulters. Gastroenterology 1992; 102: 1962-7.
3. Osterberg E, Blomquist L, Krakau I et al. A population study on irritable bowel syndrome and mental health. Scand J Gastroenterol 2000; 35: 264-8.
4. Ehlin AGC, Montgomery AM, Ekbom A et al. Prevalence of gastrointestinal diseases in two British national birth cohorts. Gut 2003; 52: 1117-21.
5. Wilson S, Roberts L, Roalfe A et al. Prevalence of irritable bowel syndrome: A community survey. Br J Gen Pract 2004; 54: 495-502.
6. Poynard T, Regimbeau C, Benhamou Y. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2001; 15: 355-61.
7. Jackson JL, O'Malley PG, Tomkins G et al. Treatment of functional gastrointestinal disorders with antidepressant medications: A meta analysis. Am J Med 2000; 108: 65-72.
8. Agarwal OP. Prevention of artheromatous heart disease. Angiology 1985; 36: 485-92.
9. Yeh GY, Eisenberg DM, Kaptchuk TJ et al. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003; 26: 1977-94.
10. Klein AD, Penneys NS. Aloe vera. J Am Acad Dermatol 1988; 18: 714-20.
11. Choi SW, Son BW, Park YI et al. The wound healing effect of a glycoprotein fraction isolated from aloe vera. Br J Dermatol 2001; 145: 535-45.
12. Vazquez B, Avila G, Segura D et al. Anti-inflammatory activity of extracts from Aloe vera gel. J Ethnopharmacol 1996; 55: 69-75.
13. Langmead L, Feakins RM, Goldthorpe S et al. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther 2004; 19: 739-74.
14. Thompson WG, Longstreth GF, Drossman DA et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45: 1143-7.
15. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395-402.
16. Pynard T, Naveau S, Mory B, Chaput J-C. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1994; 8: 499-510.
17. Camilleri M, Northcutt AR, Kong S et al. Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomised, placebo-controlled trial. Lancet 2000; 355: 1035-40.